Loading...
•
Dec 31, 2021
ResMed Q2 2022 Earnings Report
ResMed's second-quarter results reflected continued strong performance, resulting in double-digit top-line revenue growth and solid growth in software-as-a-service business.
Key Takeaways
ResMed Inc. announced results for the quarter ended December 31, 2021. Revenue increased by 12% to $894.9 million, and diluted earnings per share were $1.37.
Revenue increased by 12% to $894.9 million; up 13% on a constant currency basis.
Diluted earnings per share of $1.37; non-GAAP diluted earnings per share of $1.47.
Income from operations increased 12%; non-GAAP operating profit up 5%.
Gross margin of 56.4%; non-GAAP gross margin contracted 230 bps to 57.6%.
Revenue by Geographic Location
Forward Guidance
No specific forward guidance was provided in the press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...